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Design of a bioreactor to study
the role of red blood cells in the
transport of nitric oxide in the
microcirculation
Nupura Bhise* and Mahendra Kavdia†

ABSTRACT
Nitric oxide (NO) plays an important role in physiological functions like vasodilation, neurotransmission, and inhibition of platelet aggregation. The endothelium-derived NO diffuses into
the vascular lumen where it interacts with flowing blood as well as the smooth muscles where it
modulates vascular tone. However, uncertainty exists on how NO escapes the rapid scavenging
by hemoglobin (Hb) and reaches smooth muscles. Several proposed hypotheses include 1) a
reduced reaction rate of NO with Hb contained inside red blood cells (RBCs) and 2) NO preservation in the bound form of s-nitrosohemoglobin or nitrite. The mechanism and magnitude of
reduction of NO reaction rate with Hb contained inside RBCs are not well established. In this
study, an in vitro experimental system was designed to expose stirred RBC suspension to physiologically relevant NO flux. NO-RBC interactions were studied by measuring the reaction products, nitrite and total NOx, using chemiluminescence method. We studied the effect of increasing
hematocrit from 5% to 45% on NO-RBC interaction under oxygenated condition. Results show
that the system maintained a steady state in the bioreactor and could be easily modified to control NO delivery flux. An increase in product concentration was observed by increasing the
hematocrit from 5% to 45%. The study is clinically important as the understanding of molecular interaction of NO with Hb in RBCs and mode of NO transport in microcirculation may provide therapeutic opportunities in the biomedical field in areas as diverse as sickle cell anemia,
septic shock, hypoxic pulmonary vasoconstriction, and blood substitutes.

* Nupura S. Bhise is a senior majoring in biological engineering.
† Dr. Mahendra Kavdia is an assistant professor in the Department of Biological and Agricultural Engineering and is
the faculty sponsor.
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INTRODUCTION
Nitric oxide (NO) mediates significant vascular
endothelium functions, including vasodilation, blood
pressure regulation, inhibition of platelet aggregation,
neurotransmission, and immunological response
(Moncada et al., 1991). In the microcirculation, NO is
synthesized via enzymatic oxidation of amino acid Larginine to L-citrulline by endothelial NO synthase
enzyme. Endothelium-derived NO diffuses into the vascular lumen where it interacts with flowing blood as well
as smooth muscles where it activates soluble guanylate
cyclase and modulates vascular tone. Discovery of NO as
endothelium-derived relaxation factor led to the awarding of a 1998 Nobel Prize in physiology to investigators
F. Murad, R.F. Furchgott, and L.J. Ignarro (Gow et al.,
1999). Subsequently many scientific investigators have
been involved in studying a possible role for red blood

cells (RBCs) in transport of NO and its vascular effect in
facilitating flow of blood through the microcirculation.
Homeostasis of NO is a balance between its synthesis
and consumption. In the lumen, NO is either oxidized
by oxygen (O2) resulting in nitrite (NO2−) formation, or
is taken up by red blood cells, which contain high concentrations of hemoglobin (Hb), an effective NO scavenger. Two important reactions of Hb and NO considered to be relevant are (a) the oxidation, in which NO
reacts with oxyHb (HbFe2+O2) to form nitrate and
metHb (HbFe3+), and (b) the addition reaction, in which
deoxyHb (HbFe2+) binds to NO to form HbFe2+NO
(HbNO). Due to this high reactivity of NO with Hb and
other species, NO may be consumed before it travels
from its synthesis site (endothelium) to target site
(smooth muscle). Earlier studies thus assumed that the
only effect of RBCs on the bioactivity of NO was to scavenge and inactivate NO, thus limiting its ability for
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vasodilation (Nagababu et al., 2003). However, the NO
bioactivity is preserved in the blood under normal physiological conditions. Scientists trying to investigate how
NO escapes rapid scavenging by Hb have proposed various hypotheses including (a) an erythrocyte-free layer
in the lumen adjacent to the endothelium that provides
an effective diffusional barrier; (b) about a 500- to 1000times lower effective reaction rate of NO with Hb contained in RBC than that with free Hb, k ≈ 107 M-1 s-1
(Huang et al., 2001; Liu et al., 2002); and (c) NO preservation in the bound form of s-nitrosohemoglobin
(sNOHb) (Gow et al., 1999; Pawloski et al., 2001;
McMahon et al., 2002).
In spite of these studies, individual roles of these proposed factors for regulation of vascular functions remain
largely unknown. Uncertainty also exists on the mechanism responsible for NO preservation and the magnitude of effective reaction rate of NO with RBCs and its
relationship with hematocrit and flow. To overcome the
technical difficulties of in vivo determination of the local
availability of NO and study this relationship, we
designed an in vitro constantly stirred experimental
setup that simulates in vivo conditions of NO synthesis
and consumption. We delivered NO at a constant flux to
a constantly stirred RBC solution in the bioreactor and
measured the products of RBC-NO interaction: nitrite
(NO2−) and total NO-species (NOx), using a gas-phase
chemiluminescence method.
The in vitro studies provide a critical step in quantifying NO uptake by varying the hematocrit concentration from 5% to 45% in oxygenated condition and
extend our understanding of the functional role of NO
in the microcirculation. This knowledge is critical to
development of hemoglobin-based oxygen carriers
(HBOCs) that are under development as an alternative
to RBC transfusion because of the potential advantages
of unlimited supply, no cross-matching requirement,
chemical purity and prolonged storage (Winslow, 2000).
The understanding of molecular interaction of NO with
Hb and NO transport is clinically important and may
provide therapeutic opportunities in areas as diverse as
sickle cell anemia, septic shock, NO inhalation, hypoxic
pulmonary vasoconstriction, and blood substitutes
(HBOCs).

MATERIALS AND METHODS
Materials.
All the chemicals—sodium iodide (NaI), sodium
nitrate (NaNO3), sodium nitrite (NaNO2), phosphate
saline buffer (PBS), EDTA, vanadium (III) chloride
(VCL3), sodium hydroxide (NaOH), and free Hb—were
American Chemical Society (ACS) grade and purchased

from Sigma–Aldrich (St Louis, Mo.). Glacial acetic acid
(ACS grade) and 12 M hydrochloric acid (HCl, ACS grade)
were obtained from VWR International (Fayetteville, Ar.).
Thereafter, 1-mM stock solutions of NaNO2 and NaNO3
were prepared in de-ionized (DI) water and 4 mM PBS
were prepared by dissolving one 10X PBS packet in 1000
ml DI water with 2 g of glucose added to it. Saturated VCl3
solution was prepared by dissolving 0.8 g of VCl3 in 100 ml
of 1 M HCl and DI water and a 0.2 M solution of NaI was
prepared by dissolving 0.29978 g of NaI in de-ionized
water.
Design of an in vitro experimental system for RBC-NO
interaction studies.
In this study, a continuously stirred novel bioreactor
device was designed that replicated in vivo conditions of
NO generation and consumption in blood vessels. All the
reactions were conducted using this experimental system
(figures 1A and 1B). A 100-ml Pyrex bottle was used as the
bioreactor with a controlled headspace and stirring device
for the experimental solutions. The headspace cover
included two openings (to serve as inlet and outlet for
gaseous mixture) and a third sample collection port. These
openings consisted of Swage-lock fittings glued into holes
drilled in the bottle cover. Controlled gas-flow meters
(Porter Instrument Co. Hatfield, Pa.) were used to balance
the gas mixture and obtain a specified NO concentration
from gas cylinders entering the bioreactor, where NO
reacted with 10 ml of treatment solution. Flow rate of gas
mixture into the headspace consisted of 100 ml/min of
100% ultra-high pure nitrogen and desired ml/min of
10% NO/N2. The gas mixture was allowed to flow across
stainless steel tubing to the inlet of the bioreactor in the
chemical safety hood. The solution was continuously
stirred with a magnetic stirrer at a constant speed of 2 rpm.
To characterize the bioreactor in terms of NO delivery, we
treated 10 ml of DI water at two different NO fluxes, and
100 µl samples were collected at 1, 2, 3, 4, 5, and 10 min.
Nitrite concentration was measured in collected samples
using chemiluminescence method. Next we conducted a
variable-time experiment with 5% oxygenated RBC solution and measured both the nitrite and total NOx concentrations. The ability of the device to study NO-RBC interactions was validated by treating oxygenated RBC solution
at 5% and 45% hematocrit and measuring the respective
reaction products.
Preparation and treatment of 5% and 45% RBC solutions.
Approximately 100 ml of pig blood were collected from
the Savoy Experimental Farm, University of Arkansas, in
10-ml heparinized tubes (Vacutainer). Blood was centrifuged at RCF= 800g, RCM= 2713, Time= 10 min and
Temperature= 4°C. Plasma was pipetted out and RBCs
were washed thrice with 2-3 mL refrigerated PBS solution

THE STUDENT JOURNAL OF THE DALE BUMPERS COLLEGE OF AGRICULTURAL, FOOD AND LIFE SCIENCES

31

(4 mM PBS + 2 g glucose). After separation of RBCs, the
RBC/PBS solution was stored at 4°C to prepare the hematocrit solutions. Thereafter, 1 ml of RBC, obtained by centrifugation of pig blood, was mixed with 19 ml of prepared
PBS solution to prepare 20 ml of 5% RBC solution, and 9
ml of RBC were mixed with 11 ml of PBS solution to
obtain 20 ml of 45% RBC solution. For both the variabletime and variable-hematocrit experiments, 10 ml of the
prepared RBC solution were treated for 10 minutes in the
bioreactor under oxygenated conditions. Gas flow rates
were adjusted at 100 ml/min of 100% N2 and 0.7 ml/min
of 10% NO/N2 mixture, and the solution was constantly
stirred.
Collection of samples.
For variable-time experiments, about 0.3 ml of blood
samples were collected with a 1-ml syringe into eppendorf
tubes at regular intervals of 2 min from the instant the
NO/N2 treatment (0-min blank sample) started till the end
of the treatment (10-min sample). For variable-hematocrit
experiments, only the blank blood sample (0 min) and the
end sample (10 min) were collected. Then 1 µM, 5 µM, 10
µM, 50 µM, and 100 µM concentrations of NaNO2 and
NaNO3 standard samples were prepared from the respective 1-mM stock solutions. The NaNO2 and NaNO3 standard curves were used to quantify the products NO2− and
total NOx, respectively.
Chemiluminescence method for measurement of reaction
products.
The Model 280i Nitric Oxide Analyzer (NOA) from
Sievers Instruments (Boulder, Colo.), a high-sensitivity
detector with a detection limit of 1 picomole, was used for
measuring NO based on a gas-phase chemiluminescent
reaction between NO and ozone. The purge-vessel setup
was used to detect NO2− and a gas-bubbler NaOH trap was
added to the setup to measure total NOx. Argon that bubbled through the purge vessel carried any released NO to
the NO detector. NO reacts with dissolved oxygen to form
NO2−. To measure NO2−, the purge vessel was filled with a
reducing agent (l% wt/vol of NaI or KI in glacial acetic
acid) to convert NO2− to NO, which was then carried to the
NOA for detection. The reaction converting NO2− to NO,
I-+ NO2-+ 2H+ g NO + l/2I2+ H2O (Equation 1)

For most applications, ~8 ml (2 ml NaI and 6 ml acetic
acid) of the reducing agent were prepared in the purge vessel, as this volume was sufficient for measurement of 20-50
samples, depending on the volume of the sample injected.
The reagent was changed when the solution turned yellow
due to formation of I3-, indicating depletion of the reducing agent.

32

NO reacts with oxyHb to form NO3-. To measure total
NOx, about 5 ml of vanadium (III) chloride in hydrochloric acid were used as the reducing agent to convert NO3- to
NO,
2NO3-+3V+3+2H2Og2NO + 3VO2+ + 4H+ (Equation 2)
To avoid foaming of the blood samples, 100 µl of
antifoaming agent were injected into the reducing agent.
To achieve high conversion efficiency, the reduction was
performed at ~90°C.
For volumes corresponding to 100 µl of standard samples, 10 µl of blood samples for NO2− and 5 µl of blood
samples for total NOx were injected through a septum into
the purge vessel to obtain concentration-dependent
chemiluminescent signals in millivolts (mV). A calibration
curve was prepared by plotting concentrations of standard
solutions versus peak mV signals.
Statistics.
The DI-water experiments were conducted twice,
changing the NO delivery rate. The experiments for 5%
and 45% hematocrit were repeated three times under oxygenated conditions. The results presented were in the form
of mean ± SE.

RESULTS AND DISCUSSION
Experimental system design.
The experimental system developed in the study was
simple: to fabricate and reliably replicate the in vivo conditions of NO generation and consumption in blood vessels where flowing blood receives a constant NO flux from
the endothelium, which forms the first layer of the vascular wall. The solution could be treated with a desired
NO/N2 flux for the complete duration of the experiment
using the digitally controlled mass-flow meter and the
setup could be modified to vary the NO+N2 delivery rate
into the solution in the bioreactor. The sample collection
port on top facilitated a convenient withdrawal of sample
from the solution without significant disturbance to the
experimental conditions. The gas outlet port prevented
buildup of gases in the bioreactor. Continuous stirring of
the solution minimized effects of any effective diffusional
barrier due to the unstirred layer surrounding the RBC,
which is responsible for preserving NO bioactivity (Liu et
al., 2002).
So far the majority of studies have been performed
using NO-delivery systems like direct injection of saturated solutions of NO (Han et al., 2002; Joshi et al., 2002;
Han et al., 2004) and NO donors (Vaughn et al., 2000).
Disadvantages of using these direct-delivery systems are
that they can cause significant loss of NO from the exper-
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imental system (Kavdia and Lewis, 2003) and create high,
localized concentrations of NO that react instantaneously
before reaching uniform concentration in the system.
They also contain nitrite as an impurity, which can affect
the interpretation of RBC-NO interaction products
(Nagababu et al., 2003). This in vitro, controlled, gaseous
NO-delivery system helped to overcome technical difficulties involved in in vivo determination of local availability of the gas, maintained a homogeneous concentration
of NO in the reaction environment, and also eliminated
the possibility of product contamination. The system thus
allowed RBC-NO reactions to take place as a steady state
was maintained on both the liquid side and gaseous side,
which more accurately simulated the physiological conditions in microcirculation.
Nitrite and total NOx standard curves to quantify the treated samples.
Standard samples of NO2− and NO3− were injected into
the NO analyzer to generate standard curves for both
nitrite and total NOx concentrations, respectively. Fig. 2A
shows the chemiluminescent signal (mV) recorded by the
NO analyzer after injecting standard nitrite samples in
concentrations of 1, 5, 10, and 50 µM. Fig. 2B shows the
peak mV value for each concentration of standard nitrite
sample. Similarly, figures 3A and 3B show the chemiluminescent signal and peak mV signal, respectively, for total
NOx concentrations of 1, 5, 10, 50, and 100 µM.
The peak mV signals showed a linearly increasing
trend with increases in nitrite and total NOx concentrations. The standard curve data established a linear relationship between the standard concentration and peak
mV signal. Thereafter, before injecting treated samples, a
1-µM standard sample was injected every time the reducing agent in the purge vessel was changed. The concentration of the treated sample was calculated using the formula,
[Sample peak signal (mV) - Sample base signal (mV)]
× Dilution factor
[Standard peak signal (mV) - Standard base signal (mV)]

(Equation 3)
where the base signal was the lowest value recorded before
injecting the sample or standard and the peak value was
the highest mV signal obtained after injecting the sample
or standard.
DI water experiments to characterize the NO-delivery rate
of the experimental system.
To characterize the experimental system, we conducted experiments by treating 10 ml DI water in the bioreactor and studied the effect of changing the gaseous partial
pressure in headspace on the total NO-delivery rate
(moles/min). Fig. 4A shows the NOA signal recorded for
the nitrite analysis of DI water samples collected at reac-

tion times 0, 2, 4, 6, 8, and 10 min, when treated with a
flow rate of 0.7 ml of 10% NO/N2 + 100 ml of 100% N2.
Fig. 4B shows the nitrite concentration profile for DI
water samples collected at regular reaction-time intervals.
Similarly, figures 5A and 5B show the NOA signal and
nitrite-concentration profile for DI water samples collected at reaction times 0, 1, 2, 3, 4, 5, and 10 min, conducted
at flow rates of 1.5 ml of 10% NO/N2 + 100 ml of
100% N2.
From the best-fit trend-line (figures 4B and 5B), we
noted a linear increase in nitrite concentration with each
successive time sample injected from 0 min to 10 min for
both cases. Slope obtained from the best-fit linear trendline gave the delivery rate of NO in units of µM/min. NO
delivery rate was converted to moles/min using the
relationship,

moles = concentration x volume

(Equation 4)

where the volume was 10 ml. NO-delivery rates calculated using Equation 4 were 3.853 nmoles/min for a flow rate
of 0.7 ml of 10% NO/N2 + 100 ml of 100% N2, and 22.22
nmoles/min for a flow rate of 1.5 ml of 10 % NO/N2 + 100
ml of 100% N2.
The results indicated that the NO-delivery rate
increased about 5.77 times as the 10% NO+N2 flow rate
increased from 0.7 ml/min to 1.5 ml/min. Nitrite concentration was time-dependent. With an increase in time
during which the DI water solution was allowed to react
with NO/N2 gaseous mixture, there was a linear increase
in the nitrite concentration in the solution. The NO reacts
with dissolved O2 to form nitrite, with a reaction rate
KCNO2CO2, where K = 9.8 x 106 m-2s-1. This implied that the
experimental system was able to maintain a constant NOdelivery rate in the solution during the entire duration of
the treatment and NO was allowed to mix homogenously
throughout the stirred solution. Thus our system has an
advantage over systems in which addition of NO bolus
causes rapid initial reaction before NO is homogenously
mixed throughout the solution (Joshi et al., 2002). The
results proved that this in vitro system can be used to treat
RBC solution with a constant NO flux, thereby more
accurately replicating in vivo conditions of RBC-NO
interactions. Thus using these preliminary data of nitrite
formation with DI water, we were able to characterize the
experimental system.
Nitrite and total NOx levels in 5% oxyRBC solution.
Next, we treated 10 ml of 5% oxy RBC solution with
0.7 ml of 10% NO/N2 + 100 ml of 100% N2 for 10 min,
regularly collecting samples at reaction times of 0, 2, 4, 6,
8, and 10 min. Figures 6A and 6B show the nitrite- and
total NOx-concentration profiles, respectively, for these
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samples. The results showed that as treatment time
increased from 2 min to 10 min, concentrations increased
from 1.23 µM to 2.79 µM for nitrite and 10.3 µM to 25.1
µM for total NOx. There was a linear increase in nitrite
and total NOx concentrations as reaction time between
5% oxy RBC and NO increased. Figure 6C shows percent
ratio of nitrite to total NOx in the 5% oxy RBC samples at
different time points. The ratio remained almost constant
at 11.87 ± 0.876% for 2-10 min.
Results indicate that our system maintained a steadystate at both gaseous and liquid levels in the bioreactor.
Oxygenated RBCs rapidly scavenged NO at an uptake rate
of 21.9 nmoles/min calculated from the total NOx linearconcentration profile. Also nitrite was formed as a relatively minor portion of the total NOx species, suggesting
that the major part of the reaction products formed were
either in the stable nitrate form or other intermediate
species like S-nitrosithiols. Although nitrite is the main
product of NO oxidation in blood plasma (equation 5),
upon interaction with oxygenated heme domains in RBC,
however, NO is rapidly oxidized to form nitrate and
metHb (equation 6a). Our experiments suggest that the
oxidation product nitrate is formed at a higher concentration than the conservation product nitrite. Similar observations were reported by Liao and colleagues, who conducted experiments by generating NO homogenously
using NO donors (Joshi et al., 2002). Thus nitrite and
other NO-species like SNOHb, a product of s-nitrosation
(Equation 6b), and HbFe(II)NO, a product of reductive
nitrosylation (equations 6c and 6d), may be formed that
contribute to the conservation of NO bioavailability in
the microcirculation (McMahon et al., 2002), but the consumption reaction dominates the RBC-NO interaction in
physiological conditions.
Oxidation of NO,
2NO + 1/2O2 + H2Og 2NO2- + 2H+ (Equation 5)
Reaction of NO with oxyRBC,
NO+oxyHb [HbFe(II)O2]g metHb [HbFe(III)] + nitrate
[NO -] (Equation 6a)
3

S-nitrosation of metHb,
metHb [HbFe(III)] + NOg SNOHb (Equation 6b)
Reductive nitrosylation of metHb,
metHb [HbFe(III)] + NOg NO+ + HbFe(II)
(Equation 6c)
HbFe(II) + NOg HbFe(II)NO (Equation 6d)
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Effect of variable hematocrit on nitrite and total NOx levels
in oxygenated RBC solution.
Products of the NO reaction with the RBC-encapsulated Hb depend on the concentration of the hematocrit and
to study this effect, we conducted experiments by varying
hematocrit from both 5% to 45% in oxygenated conditions. Three separate sets of experiments were conducted
and mean values were plotted with standard error bars.
Figures 7A and 7B show the comparison of nitrite and
total NOx concentrations, respectively, for samples collected at 10 min for each hematocrit percentage. The mean
nitrite concentrations increased from 3.73 ± 1.17 µM for
5% hematocrit to 5.61 ± 3.73 µM for 45% hematocrit.
Total NOx concentrations also increased from 34.4 ±
10.82 µM for 5% to 40.2 ± 7.68 µM for 45% hematocrit.
Mean nitrite concentration increased 1.5 times and total
NOx concentration increased 1.17 times as the hematocrit
was increased from 5% to near physiological range of
45%. Figure 7C shows the comparison of nitrite to total
NOx-percent ratio for the two oxy RBC solutions. The
ratio also increased from 10.84 ± 4.28% for 5% hematocrit to 13.96 ± 10.93% for 45% hematocrit solution.
As NO reacts homogenously with increased concentration of RBC in the solution, there is an increased scavenging of NO by RBC-encapsulated Hb, thereby increasing
the concentration of total NOx (Azarov et al., 2005).
Nitrite is formed as a product of oxygenation reaction of
NO with O2 in solution (equation 5) before NO can be
rapidly scavenged by RBC-encapsulated Hb. Availability
of higher levels of O2 in oxygenated condition and more
O2-bound heme Fe (II) sites to react with NO at higher
hematocrit results in an increase of the nitrite concentration in oxygenated solution. Nitrite was formed in the
range of 11 to 13% of the total NOx species. Formation of
the conservation product, nitrite, as a minor species indicates that NO and oxyRBC interaction is dominated by
the consumption reaction to form metHb and nitrate
(equation 6a). The dominance of the consumption pathway was observed by Gladwin and colleagues, and also in
experiments conducted by Liao and colleagues using NO
donors (Gladwin et al., 2000; Han et al., 2004). Liao and
colleagues further reported that in experiments conducted using saturated NO bolus, intermediate species like
SNOHb and HbFe(II)NO were formed as minor portions
of the total NOx species. But research groups have reported different values for concentration of these minor
species (McMahon et al., 2002), and have indicated that
since these conservation species form a very small portion
of the total NOx species, their physiological significance in
preserving NO remains unclear. Hence, using the experi-
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mental system designed in this study, we found that NORBC interactions were dominated by the consumption
reaction, forming nitrate and metHb [HbFe(III)].
Conclusions
Our results help to explain the mechanism of physiological regulation of NO bioactivity by alteration of RBC
concentration and NO delivery rate, and thereby significantly increase our understanding of the interactions of
NO with RBCs in the vasculature. The experimental setup
allowed maintaining a steady state in the bioreactor as a
constant NO flux reacted with the RBC solutions, thus
effectively replicating the in-vivo conditions in microcirculation. The setup also could be easily modified to control the NO flux delivered into the solution. Results
showed that for oxygenated solution, the nitrite and total
NOx concentrations increased as the hematocrit increased
from 5% to 45%. This deeper understanding of the multiple facets of RBC and NO biology will provide important insights into mechanisms of vascular homeostasis
and will offer novel therapeutic strategies for treatment of
vascular-related pathologies
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Figure 1: A. The schematic
experimental
B. The experimental
system
setup
in the laboratory.
B. The experimental
system setup
in the
laboratory.
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